Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.640
+0.040 (2.50%)
At close: Jan 17, 2025, 4:00 PM
1.650
+0.010 (0.61%)
After-hours: Jan 17, 2025, 7:58 PM EST
PACB Employees
Pacific Biosciences of California had 796 employees as of December 31, 2023. The number of employees increased by 27 or 3.51% compared to the previous year.
Employees
796
Change (1Y)
27
Growth (1Y)
3.51%
Revenue / Employee
$217,521
Profits / Employee
-$495,276
Market Cap
449.14M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PACB News
- 6 days ago - PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics - GlobeNewsWire
- 6 days ago - PacBio Announces Preliminary Fourth Quarter and Full Year Revenue - GlobeNewsWire
- 10 days ago - PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing - GlobeNewsWire
- 18 days ago - PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight - Benzinga
- 2 months ago - Pacific Biosciences' Cost Cuts Won't Offset Rising Competition - Seeking Alpha
- 2 months ago - PacBio to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Pacific Biosciences of California, Inc. (PACB) Q3 2024 Earnings Call Transcript - Seeking Alpha